ABRA Abdominal Closure System in Open Abdomen Management
NCT00754156 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2017-03-03
Summary
For the last 20 to 30 years, damage control laparotomy and decompressive laparotomy have emerged as part of the armamentariums for treatment of complex abdominal trauma, abdominal compartment syndrome, and critically ill surgical patients with profound acidosis. While these advances have saved lives, they have also led to a dramatic increase in patients with open abdominal cavities. Various methods have been employed to offer protection to the viscera and at the same time, encourage gradual closure of the abdominal fascia. Some of the techniques have included the Bogota bag, vacuum pack described by Barker , Wittman patch , and the use of vacuum assisted fascia-closure, including the commercially available system offered by KCI. Overall, the abdominal closure rate is approximately 50% to 90% over an average of 10 days. Unfortunately, there has been no well-designed comparison study available. Some of the best results also require returning to the operating room every 3 to 5 days.
At the University of Kentucky Medical Center, a combination of the vacuum pack dressing described by Barker, the commercially available VAC system (V.A.C.; KCI International, San Antonio, TX) and vicryl mesh closure systems are used. The primary fascial closure rate is approximately 50%. It is not standard practice to take patients to the OR every 3-5 days routinely.
Recently, a new FDA listed system (ABRA by Canica) has been introduced using a progressive tension system as a novel approach to the management of open abdomen. ABRA provides a dynamic reduction of full thickness, severely retracted midline abdominal defects with the goal of maintaining or restoring the primary closure option. This subdermal method uses button anchors and elastomer to gradually pull the wound margins together. Tension can be set and adjusted according to the desired outcome; to stabilize a retracted wound, reduce the wound, close the wound or prevent wound dehiscence (Attachment 1: Company brochure). Currently there is only one published case report of the success of this device. We hope to be the first center to prospectively report a series of patients with open abdomen managed with the new ABRA system. In this study, this system will be used in combination with a standard therapy used in abdominal wound closure at the University of Kentucky Medical Center. This system is called the V.A.C system (V.A.C.; KCI International, San Antonio, Tx). This therapy provides active exudate management and containment, assists in reducing abdominal volume and adds structural stabilization to adipose tissue.
Although no highly powered study has been done to establish data on performance, individual experiences at several institutions have reached fascial closure rates of higher than 70% using the ABRA device. One institution in Las Vegas, Nevada is using the ABRA device in combination with the VAC system and has experienced 100% closure rate to date with 12 patients. The purpose of this study is to collect information about the ABRA system in combination with the VAC technique at the University of Kentucky Medical Center. It is our belief that using this system will improve the fascial closure rate and thereby produce less chance of hernia and reduce long periods of open abdominal wounds. The objective of the study is to evaluate a novel approach for closure of open abdomen utilizing the Canica ABRA system combined with the K.C.I. VAC System to KCI VAC System alone.
Conditions
- Open Abdomen
Interventions
- DEVICE
-
ABRA Abdominal Closure System
ABRA Abdominal Closure System
- DEVICE
-
V.A.C. Therapy
V.A.C. Therapy Alone
- DEVICE
-
KCI ABThera
KCI ABThera
Sponsors & Collaborators
-
Anna Rockich
lead OTHER
Principal Investigators
-
Phillip Chang, M.D. · University of Kentucky
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
A New Abdomen Closure Technology Based on Component Separation: a Prospective Randomized Controlled Trial
NCT03111134 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Different Types of Temporary Abdominal Closure on Intra Abdominal Hypertension.
NCT02229695 ·Status: UNKNOWN
-
Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen
NCT05568238 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Non-Comparative Study of Open Abdomen That Require the Use of Negative Pressure Wound Therapy (NPWT) for Temporary Abdominal Closure
NCT03431220 ·Status: WITHDRAWN ·Phase: NA
-
Closed or Open Abdomen for the Management of Abdominal Sepsis
NCT03163095 ·Status: RECRUITING ·Phase: NA
-
Vacuum Assisted Wound Closure (VAWC) and Mesh Mediated Fascial Traction
NCT00494793 ·Status: COMPLETED ·Phase: NA
-
Randomized Pilot Study Comparing Two Vacuum-wound-dressings for Open Abdomen Treatment
NCT00834314 ·Status: TERMINATED ·Phase: NA
-
Use of 2-octyl-cyanoacrylate Together With a Self-adhering Mesh
NCT01658163 ·Status: COMPLETED
-
Delayed Primary Closure Using Negative Pressure Wound Therapy
NCT04042259 ·Status: RECRUITING ·Phase: NA
-
Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study
NCT04033614 ·Status: RECRUITING ·Phase: NA
-
Plastic Wound Retractors and Bacterial Translocation in Abdominal Surgery
NCT01007487 ·Status: COMPLETED
-
Irrigation Versus Suction in Complicated Acute Appendicitis
NCT02688244 ·Status: UNKNOWN ·Phase: NA
-
Using Vaccum Assisted Closure of Wound Instead of Primary Closure As Prophylactic Way Against Burst Abdomen
NCT06732024 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Role of VAC Therapy Devices in Promoting Closure of Enterocutaneous Fistulae
NCT02519192 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of Sacrospinous Ligament Fixation and Uterosacral Ligament Suspension for Apical Prolapse Surgery: A Randomized Clinical Trial
NCT05668130 ·Status: UNKNOWN ·Phase: NA
-
Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
NCT00284739 ·Status: COMPLETED ·Phase: PHASE2
-
Wound Infection Alexis Wound Retractor
NCT00323453 ·Status: COMPLETED ·Phase: NA
-
Anchor for Robotic Sacrocolpopexy
NCT03378622 ·Status: UNKNOWN ·Phase: PHASE3
-
Band Adhesions in Relation to Previous Abdominal Surgery
NCT03663023 ·Status: COMPLETED
-
Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments
NCT01528033 ·Status: COMPLETED ·Phase: NA
-
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
NCT00802633 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions
NCT00512356 ·Status: COMPLETED ·Phase: PHASE2
-
Closure of the Appendiceal Stump
NCT06443749 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of DERMABOND ProPen in Closure of Colectomy Wounds
NCT00978133 ·Status: TERMINATED ·Phase: PHASE2
-
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
NCT01594385 ·Status: COMPLETED ·Phase: NA